Randomised Controlled Trials Assessing the Clinical Value of Urodynamic Studies: A Systematic Review and Meta-analysis.

Lower urinary tract symptoms Prostatic hyperplasia Stress Urinary incontinence Urodynamics

Journal

European urology open science
ISSN: 2666-1683
Titre abrégé: Eur Urol Open Sci
Pays: Netherlands
ID NLM: 101771568

Informations de publication

Date de publication:
Oct 2022
Historique:
accepted: 14 08 2022
entrez: 16 9 2022
pubmed: 17 9 2022
medline: 17 9 2022
Statut: epublish

Résumé

The role of urodynamic studies (UDSs) in the diagnosis of lower urinary tract symptoms (LUTS) is crucial. Although expert statements and guidelines underline their value for clinical decision-making in various clinical settings, the academic debate as to their impact on patient outcomes continues. To summarise the evidence from all randomised controlled trials assessing the clinical usefulness of UDS in the management of LUTS. For this systematic review, searches were performed without language restrictions in three electronic databases until November 18, 2020. The inclusion criteria were randomised controlled study design and allocation to receive UDS or not prior to any clinical management. Quality assessment was performed by two reviewers independently, using the Cochrane Collaboration's tool for assessing the risk of bias. A random-effect meta-analysis was performed on the uniformly reported outcome parameters. Eight trials were included, and all but two focused on women with pure or predominant stress urinary incontinence (SUI). A meta-analysis of six studies including 942 female patients was possible for treatment success, as defined by the authors (relative risk 1.00, 95% confidence interval: 0.93-1.07), indicating no difference in efficacy when managing women with UDS. Although UDSs are not replaceable in diagnostics, since there is no other equivalent method to find out exactly what the lower urinary tract problem is, there are little data supporting its impact on outcomes. Randomised controlled trials have focussed on a small group of women with uncomplicated SUI and showed no added value, but these findings cannot be extrapolated to the overall patient population with LUTS, warranting further well-designed trials. Despite urodynamics being the gold standard to assess lower urinary tract symptoms (LUTS), as it is the only method that can specify lower urinary tract dysfunction, more studies assessing the clinical usefulness of urodynamic studies (UDSs) in the management of LUTS are needed. UDS investigation is not increasing the probability of success in the treatment of stress urinary incontinence.

Identifiants

pubmed: 36110903
doi: 10.1016/j.euros.2022.08.013
pii: S2666-1683(22)00883-7
pmc: PMC9469658
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

131-141

Informations de copyright

© 2022 The Authors.

Références

BJU Int. 2020 Jul;126(1):4-5
pubmed: 32279404
F1000Res. 2019 May 9;8:
pubmed: 31119030
Obstet Gynecol. 2013 May;121(5):999-1008
pubmed: 23635736
Med Decis Making. 1991 Apr-Jun;11(2):88-94
pubmed: 1907710
Nat Clin Pract Urol. 2005 Nov;2(11):555-64
pubmed: 16474599
Eur Urol Focus. 2020 Jan 15;6(1):137-145
pubmed: 30061075
N Engl J Med. 2012 May 24;366(21):1987-97
pubmed: 22551104
J Urol. 2006 Jul;176(1):22-8
pubmed: 16753359
Eur J Obstet Gynecol Reprod Biol. 2020 Jan;244:35-37
pubmed: 31731022
Neurourol Urodyn. 2012 Sep;31(7):1118-23
pubmed: 22488817
Eur Urol Focus. 2020 Sep 15;6(5):880-908
pubmed: 31866095
J Urol. 2003 Feb;169(2):529-33; discussion 533-4
pubmed: 12544302
Scand J Urol Nephrol. 2000 Jun;34(3):169-74
pubmed: 10961470
Korean J Urol. 2014 Dec;55(12):821-7
pubmed: 25512817
Lancet. 2000 Nov 25;356(9244):1844-7
pubmed: 11117930
J Urol. 2011 Aug;186(2):597-603
pubmed: 21683412
Turk J Urol. 2019 Feb 05;45(3):157-163
pubmed: 30817272
Int Braz J Urol. 2003 Sep-Oct;29(5):418-22
pubmed: 15745586
J Chronic Dis. 1986;39(4):295-304
pubmed: 3958116
Eur Urol. 2020 Nov;78(5):701-710
pubmed: 32616406

Auteurs

Nicolas S Bodmer (NS)

Department of Neuro-Urology, Balgrist University Hospital, University of Zürich, Zürich, Switzerland.
Medignition Inc., Research Consultants, Zürich, Switzerland.

Carla Wirth (C)

Department of Neuro-Urology, Balgrist University Hospital, University of Zürich, Zürich, Switzerland.
Medignition Inc., Research Consultants, Zürich, Switzerland.

Veronika Birkhäuser (V)

Department of Neuro-Urology, Balgrist University Hospital, University of Zürich, Zürich, Switzerland.

Andrea M Sartori (AM)

Department of Neuro-Urology, Balgrist University Hospital, University of Zürich, Zürich, Switzerland.
Institute for Regenerative Medicine, University of Zürich, Zürich, Switzerland.

Lorenz Leitner (L)

Department of Neuro-Urology, Balgrist University Hospital, University of Zürich, Zürich, Switzerland.

Marcio A Averbeck (MA)

Department of Urology, Moinhos de Vento Hospital, Porto Alegre, Brazil.

Stefan de Wachter (S)

Department of Urology, University Hospital Antwerp, University of Antwerp, Antwerp, Belgium.

Enrico Finazzi Agro (E)

Department of Surgical Sciences, University of Rome Tor Vergata, Rome, Italy.
Urology Unit, Policlinico Tor Vergata University Hospital, Rome, Italy.

Andrew Gammie (A)

Bristol Urological Institute, Southmead Hospital, Bristol, UK.

Howard B Goldman (HB)

The Cleveland Clinic Foundation, Glickman Urological Institute, Cleveland, USA.

Ruth Kirschner-Hermanns (R)

Neuro-Urology/Urology, University Clinic, Friedrich Wilhelms University Bonn, Bonn, Germany.
Johanniter Neurological Rehabilitation Centre, Bonn, Germany.

Peter F W M Rosier (P)

Department of Urology, University Medical Centre Utrecht, Utrecht, The Netherlands.

Maurizio Serati (M)

Department of Obstetrics and Gynecology, Urogynecology Unit, University of Insubria, Varese, Italy.

Eskinder Solomon (E)

Urology Centre, Guy's and St Thomas' NHS Trust, London, UK.

Gommert van Koeveringe (G)

Department of Urology, Maastricht University Medical Centre, Maastricht, The Netherlands.

Lucas M Bachmann (LM)

Medignition Inc., Research Consultants, Zürich, Switzerland.

Thomas M Kessler (TM)

Department of Neuro-Urology, Balgrist University Hospital, University of Zürich, Zürich, Switzerland.

Classifications MeSH